Northern California Melanoma Center/St. Mary's Medical Center

San Francisco, California 94117

0 studies enrolling now · 2 studies all time

What they study most

Melanoma

Studies at this site

• A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma — Stopped early
• Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma — Completed